GlaxoSmithKline Pakistan Limited operates within the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares GlaxoSmithKline Pakistan Limited with three other
companies in this sector in Pakistan:
Ferozsons Laboratories Limited
sales of 11.34 billion Pakistan Rupees [US$107.68 million]
Abbott Laboratories (Pakistan) Ltd
(23.39 billion Pakistan Rupees [US$222.19 million]
of which 74%
was Pharmaceutical), and
Sanofi Aventis Pakistan Ltd
(11.89 billion Pakistan Rupees [US$112.96 million]
During the year ended December of 2016, sales at
GlaxoSmithKline Pakistan Limited were 27.56 billion Pakistan Rupees (US$261.85 million).
increase of 15.7%
versus 2015, when the company's sales were 23.82 billion Pakistan Rupees.
Despite this increase, sales are still
below the level achieved in 2014, when GlaxoSmithKline Pakistan Limited
reported sales of 27.88 billion Pakistan Rupees.